Waystar (NASDAQ:WAY – Get Free Report) will likely be issuing its Q2 2026 results after the market closes on Wednesday, July 29th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $316.2240 million for the quarter. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. Individuals can check the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Wednesday, July 29, 2026 at 4:30 PM ET.
Waystar (NASDAQ:WAY – Get Free Report) last issued its earnings results on Wednesday, April 29th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.03. Waystar had a net margin of 10.90% and a return on equity of 6.99%. The firm had revenue of $313.87 million for the quarter, compared to analysts’ expectations of $311.74 million. During the same quarter last year, the business earned $0.32 earnings per share. The business’s revenue was up 22.4% on a year-over-year basis. On average, analysts expect Waystar to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Waystar Stock Down 2.6%
Shares of NASDAQ WAY opened at $21.51 on Wednesday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.37. Waystar has a 52 week low of $17.26 and a 52 week high of $41.47. The firm’s fifty day moving average is $20.26 and its 200 day moving average is $23.73. The company has a market cap of $4.13 billion, a price-to-earnings ratio of 32.10, a PEG ratio of 0.87 and a beta of 0.08.
Institutional Inflows and Outflows
Analyst Ratings Changes
A number of equities research analysts have issued reports on the stock. Weiss Ratings lowered shares of Waystar from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, June 24th. Raymond James Financial reaffirmed a “strong-buy” rating and set a $32.00 price objective on shares of Waystar in a research note on Thursday, April 30th. JPMorgan Chase & Co. dropped their target price on shares of Waystar from $40.00 to $38.00 and set an “overweight” rating for the company in a report on Thursday, April 30th. Bank of America cut their target price on Waystar from $45.00 to $38.00 and set a “buy” rating on the stock in a research note on Friday, April 10th. Finally, KeyCorp began coverage on Waystar in a report on Wednesday, July 1st. They set an “overweight” rating and a $30.00 price target on the stock. Three analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $35.23.
Read Our Latest Analysis on Waystar
About Waystar
Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.
At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.
See Also
- Five stocks we like better than Waystar
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.
